Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Xu‐Ben Yu"'
Autor:
Xiao-Jun Cai, Yan Chen, Xiao-Shan Zhang, Yu-Zhen Wang, Wen-Bo Zhou, Chun-Hong Zhang, Bo Wu, Hui-Zhu Song, Hang Yang, Xu-Ben Yu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objectives: This study aims to characterize the population pharmacokinetics of polymyxin B in lung transplant recipients and optimize its dosage regimens.Patients and methods: This prospective study involved carbapenem-resistant organisms-infected pa
Externí odkaz:
https://doaj.org/article/30060584bfda4a71bae3d0edd9dbe749
Autor:
Xu-ben Yu, Xiao-Shan Zhang, Ye-Xuan Wang, Yu-Zhen Wang, Hong-Min Zhou, Fang-Min Xu, Jun-Hui Yu, Li-Wen Zhang, Ying Dai, Zi-Ye Zhou, Chun-Hong Zhang, Guan-Yang Lin, Jing-Ye Pan
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Presently, colistin is commercially available in two different forms, namely, colistin sulfate and its sulphomethylated derivative, colistimethate sodium (CMS). However, in the currently reported studies, most of the clinical studies on c
Externí odkaz:
https://doaj.org/article/13ed42dfb64c42aaba3889af77b11d2a
Autor:
Fan Wu, Xiao-Shan Zhang, Ying Dai, Zi-Ye Zhou, Chun-Hong Zhang, Lu Han, Fang-Min Xu, Ye-Xuan Wang, Da-Wei Shi, Guan-Yang Lin, Xu-Ben Yu, Fang Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Linezolid is associated with myelosuppression, which may cause failure in optimally treating bacterial infections. The study aimed to define the pharmacokinetic/toxicodynamic (PK/TD) threshold for critically ill patients and to identify a
Externí odkaz:
https://doaj.org/article/44d10f8c8cd04fa189b234dace9c47a9
Autor:
Jie Fang, Xiao-Shan Zhang, Chun-Hong Zhang, Zi-Ye Zhou, Lu Han, Ye-Xuan Wang, Xiao-Shuang He, Xiao-Lan Bian, Guan-Yang Lin, Zheng Jiao, Ying Dai, Xu-Ben Yu, Jing-Ye Pan
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Evidence supports linezolid therapeutic drug monitoring as the exposure–response relationship has been identified for toxicity among patients receiving linezolid, but the data to establish the upper limit are limited and the published toxicity thre
Externí odkaz:
https://doaj.org/article/c5dca0261dcb4de9b8c69163527910eb
Autor:
Yi Shi, Hai-Lan Wu, Yu-Hang Wu, Shuang Li, Li-Ya Zhang, Shan-Shan Xu, He-Yu Huang, Chun-Hong Zhang, Xu-Ben Yu, Kang Cai, Jing Zhang, Li-Su Huang
Publikováno v:
World Journal of Pediatrics. 19:129-138
Background We aimed to evaluate the tolerability and efficacy of linezolid in children for treating suspected and diagnosed Gram-positive bacterial infections. Methods A systematic literature search was conducted up to April 23, 2021, using linezolid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55d2205ed83710126a32d82ac67ce9b
https://doi.org/10.1007/s12519-022-00650-1
https://doi.org/10.1007/s12519-022-00650-1
Autor:
Xu‐Ben Yu, Yue‐Yue Huang, Xiao‐Shan Zhang, Yu‐Zhen Wang, Da‐Wei Shi, Chun‐Hong Zhang, Jie Chen, Xiao‐Rong Wang, Guan‐Yang Lin
Publikováno v:
British Journal of Clinical Pharmacology. 88:3490-3494
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff41de86d12a58cddcdb6371508a3388
https://doi.org/10.1111/bcp.15238
https://doi.org/10.1111/bcp.15238
Autor:
Guanyang Lin, Chun-Hong Zhang, Lu Han, Ye-Xuan Wang, Dawei Shi, Fan Chen, Fang-Min Xu, Xu-Ben Yu, Ziye Zhou, Ying Dai, Xiaoshan Zhang
Publikováno v:
British Journal of Clinical Pharmacology. 88:1202-1210
AIMS Data regarding clinical pharmacokinetic/toxicodynamic (PK/TD) of polymyxin B is short of direct quantitative data. This study aims to investigate the risk factors of polymyxin B associated acute kidney injury (AKI) and to assess the relationship
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46cf51ed0d19a56e28d4f4ec858fc7fb
https://doi.org/10.1111/bcp.15061
https://doi.org/10.1111/bcp.15061
Autor:
Hai-Na, Zhang1,2 (AUTHOR), Xu-Ben, Yu1,2 (AUTHOR), Cong-Rong, Tang1,2 (AUTHOR), Yan-Cheng, Cao2 (AUTHOR), Fan, Yang2 (AUTHOR), Lei-Mei, Xu2 (AUTHOR), Ruo-Lan, Sun2 (AUTHOR), Ye-Zi2 (AUTHOR), Ye-Xuan, Wang2 (AUTHOR), Jing, Liang1,2 (AUTHOR) wzlj1977@163.com
Publikováno v:
Psychopharmacology. Mar2020, Vol. 237 Issue 3, p695-705. 11p. 2 Charts, 5 Graphs.
Autor:
Lei Wang, Xu‐ben Yu, Zi‐Ye Zhou, Jue Wang, Liu‐Pu Zheng, Ying Dai, Yu‐Zhen Wang, Xiao‐Shan Zhang, Chuang Chen, Da‐Wei Shi, Chun‐Hong Zhang
Publikováno v:
Journal of clinical pharmacology.
This study aims to assess the risk factors for insufficient vancomycin concentrations for its prophylactic use in adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) and to modify dosing regimen to achieve appropriate plasma c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5750094fb0c6bcdd79c266ae869b41b8
https://pubmed.ncbi.nlm.nih.gov/36458612
https://pubmed.ncbi.nlm.nih.gov/36458612
Autor:
Xiao-Shan Zhang, Yu-Zhen Wang, Da-Wei Shi, Fang-Min Xu, Jun-Hui Yu, Jie Chen, Guan-Yang Lin, Chun-Hong Zhang, Xu-Ben Yu, Cong-Rong Tang
Publikováno v:
Infectious diseases and therapy. 11(6)
Limited data are available for ceftazidime-avibactam (CZA) dosing in patients receiving renal replacement therapy, especially the data on the dosing in patients receiving intermittent hemodialysis (IHD). In this report, we firstly described a case in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c44da65b9a73869aaae6be8cf5a67b
https://pubmed.ncbi.nlm.nih.gov/36333476
https://pubmed.ncbi.nlm.nih.gov/36333476